Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection a proof of concept randomised double blind placebo controlled phase 2A trial


Creative Commons License

Koh C., Canini L., Dahari H., Zhao X., Uprichard S. L., Williams V. H., ...More

Lancet Infectious Diseases, vol.15, pp.1167-1174, 2015 (SCI-Expanded) identifier identifier